2,5-Anhydro-D-mannitol
Latest Information Update: 17 Jul 2002
At a glance
- Originator Fujisawa
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 23 Jun 1998 Commercial data reviewed by Fujisawa
- 08 Oct 1996 Preclinical development for Type-2 diabetes mellitus in Japan (Unknown route)